These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 9849961)

  • 21. IGF-I stimulates intestinal muscle cell growth by activating distinct PI 3-kinase and MAP kinase pathways.
    Kuemmerle JF; Bushman TL
    Am J Physiol; 1998 Jul; 275(1):G151-8. PubMed ID: 9655695
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Myogenic differentiation requires signalling through both phosphatidylinositol 3-kinase and p38 MAP kinase.
    Li Y; Jiang B; Ensign WY; Vogt PK; Han J
    Cell Signal; 2000 Dec; 12(11-12):751-7. PubMed ID: 11152961
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The pleckstrin homology and phosphotyrosine binding domains of insulin receptor substrate 1 mediate inhibition of apoptosis by insulin.
    Yenush L; Zanella C; Uchida T; Bernal D; White MF
    Mol Cell Biol; 1998 Nov; 18(11):6784-94. PubMed ID: 9774692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insulin-like growth factor-1 regulates endogenous RUNX2 activity in endothelial cells through a phosphatidylinositol 3-kinase/ERK-dependent and Akt-independent signaling pathway.
    Qiao M; Shapiro P; Kumar R; Passaniti A
    J Biol Chem; 2004 Oct; 279(41):42709-18. PubMed ID: 15304489
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduced activation of phosphatidylinositol-3 kinase and increased serine 636 phosphorylation of insulin receptor substrate-1 in primary culture of skeletal muscle cells from patients with type 2 diabetes.
    Bouzakri K; Roques M; Gual P; Espinosa S; Guebre-Egziabher F; Riou JP; Laville M; Le Marchand-Brustel Y; Tanti JF; Vidal H
    Diabetes; 2003 Jun; 52(6):1319-25. PubMed ID: 12765939
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mono- or dual-phosphorylation of akt kinase is regulated by distinct receptors that involve the common insulin receptor substrate.
    Schnyder B; Lahm H; Pittet M; Schnyder-Candrian S
    J Recept Signal Transduct Res; 2002; 22(1-4):213-28. PubMed ID: 12503617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon-dependent activation of the serine kinase PI 3'-kinase requires engagement of the IRS pathway but not the Stat pathway.
    Uddin S; Majchrzak B; Wang PC; Modi S; Khan MK; Fish EN; Platanias LC
    Biochem Biophys Res Commun; 2000 Apr; 270(1):158-62. PubMed ID: 10733921
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Differential signaling by insulin receptor substrate 1 (IRS-1) and IRS-2 in IRS-1-deficient cells.
    Brüning JC; Winnay J; Cheatham B; Kahn CR
    Mol Cell Biol; 1997 Mar; 17(3):1513-21. PubMed ID: 9032279
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Muscarinic-receptor-mediated inhibition of insulin-like growth factor-1 receptor-stimulated phosphoinositide 3-kinase signalling in 1321N1 astrocytoma cells.
    Batty IH; Fleming IN; Downes CP
    Biochem J; 2004 May; 379(Pt 3):641-51. PubMed ID: 14769130
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Insulin receptor substrate (IRS) proteins IRS-1 and IRS-2 differential signaling in the insulin/insulin-like growth factor-I pathways in fetal brown adipocytes.
    Valverde AM; Lorenzo M; Pons S; White MF; Benito M
    Mol Endocrinol; 1998 May; 12(5):688-97. PubMed ID: 9605931
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Insulin-stimulated cell growth in insulin receptor substrate-1-deficient ZR-75-1 cells is mediated by a phosphatidylinositol-3-kinase-independent pathway.
    Gliozzo B; Sung CK; Scalia P; Papa V; Frasca F; Sciacca L; Giorgino F; Milazzo G; Goldfine ID; Vigneri R; Pezzino V
    J Cell Biochem; 1998 Aug; 70(2):268-80. PubMed ID: 9671232
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Insulin, insulin-like growth factor-I, and platelet-derived growth factor activate extracellular signal-regulated kinase by distinct pathways in muscle cells.
    Tsakiridis T; Tsiani E; Lekas P; Bergman A; Cherepanov V; Whiteside C; Downey GP
    Biochem Biophys Res Commun; 2001 Oct; 288(1):205-11. PubMed ID: 11594774
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Inhibition of PLC-gamma1 activity converts nerve growth factor from an anti-mitogenic to a mitogenic signal in CHO cells.
    Zapf-Colby A; Eichhorn J; Webster NJ; Olefsky JM
    Oncogene; 1999 Sep; 18(35):4908-19. PubMed ID: 10490825
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differential insulin-like growth factor I receptor signaling and function in estrogen receptor (ER)-positive MCF-7 and ER-negative MDA-MB-231 breast cancer cells.
    Bartucci M; Morelli C; Mauro L; Andò S; Surmacz E
    Cancer Res; 2001 Sep; 61(18):6747-54. PubMed ID: 11559546
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Modulation of insulin receptor substrate-1 tyrosine phosphorylation and function by mitogen-activated protein kinase.
    De Fea K; Roth RA
    J Biol Chem; 1997 Dec; 272(50):31400-6. PubMed ID: 9395471
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Insulin-like growth factor-mediated muscle differentiation: collaboration between phosphatidylinositol 3-kinase-Akt-signaling pathways and myogenin.
    Tureckova J; Wilson EM; Cappalonga JL; Rotwein P
    J Biol Chem; 2001 Oct; 276(42):39264-70. PubMed ID: 11500504
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The mitogenic and myogenic actions of insulin-like growth factors utilize distinct signaling pathways.
    Coolican SA; Samuel DS; Ewton DZ; McWade FJ; Florini JR
    J Biol Chem; 1997 Mar; 272(10):6653-62. PubMed ID: 9045696
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dual regulation of MMP-2 expression by the type 1 insulin-like growth factor receptor: the phosphatidylinositol 3-kinase/Akt and Raf/ERK pathways transmit opposing signals.
    Zhang D; Bar-Eli M; Meloche S; Brodt P
    J Biol Chem; 2004 May; 279(19):19683-90. PubMed ID: 14993222
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mitogen-activated protein kinase and phosphatidylinositol 3-kinase pathways are not sufficient for insulin-like growth factor I-induced mitogenesis and tumorigenesis.
    Scrimgeour AG; Blakesley VA; Stannard BS; LeRoith D
    Endocrinology; 1997 Jun; 138(6):2552-8. PubMed ID: 9165048
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Inhibition of insulin-like growth factor signaling pathways in mammary gland by pure antiestrogen ICI 182,780.
    Chan TW; Pollak M; Huynh H
    Clin Cancer Res; 2001 Aug; 7(8):2545-54. PubMed ID: 11489838
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.